Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Hedgehog Signaling Is Useful as a Novel Molecular Marker for Predicting Relapse and Resistance During Chronic Myeloid Leukemia Treatment.

Michele Cea, Antonia Cagnetta, Gabriella Cirmena, Anna Garuti, Ilaria Rocco, Claudia Palermo, Ivana Pierri, Marco Gobbi, MD, Alberto Ballestrero, Alessio Nencioni, Franco Patrone, Angelo Michele Carella

Blood (2010) 116 (21): 1215.

https://doi.org/10.1182/blood.V116.21.1215.1215

Published: 2010

Journal Articles

Catastrophic NAD + Depletion in Activated T Lymphocytes through Nampt Inhibition Reduces Demyelination and Disability in EAE.

Santina Bruzzone, Ph.D., Floriana Fruscione, Sara Morando, Alessandro Poggi, Anna Garuti, Martina Selmo, Tiziana Ferrando, Federica Benvenuto, Michele Cea, MD, Debora Soncini, Eva Moran, Ph.D., Ilaria Rocco, Gabriella Cirmena, Gabriele Zoppoli, MD, Alberto Ballestrero, MD, Ph.D., Bernard Sordat, Franco Patrone, Antonio Uccelli, Alessio Nencioni, MD, Ph.D.

Blood (2009) 114 (22): 4732.

https://doi.org/10.1182/blood.V114.22.4732.4732

Published: 2009

Journal Articles

Potent Synergistic Activity of the NAD+ Synthesis Inhibitor APO866 and of the Apoptosis Inducer TRAIL in in Vitro and Ex Vivo Cellular Models of Non Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia.

Blood (2009) 114 (22): 2733.

https://doi.org/10.1182/blood.V114.22.2733.2733

Published: 2009

Journal Articles

Finding of Kinase Domain Mutations at Diagnosis IN PATIENTS with Chronic PHASE Chronic Myeloid Leukemia (CP-CML) MAY Identify Those at High RISK of Disease Progression.

Angelo Michele Carella, Gabriella Cirmena, Gioacchino Catania, Gianmatteo Pica, Germana Beltrami, Alberto Ballestrero, Franco Patrone, Anna Garuti

Blood (2009) 114 (22): 4251.

https://doi.org/10.1182/blood.V114.22.4251.4251

Published: 2009

Journal Articles

APO866 activity in hematologic malignancies: a preclinical in vitro study

Michele Cea, Gabriele Zoppoli, Santina Bruzzone, Floriana Fruscione, Eva Moran, Anna Garuti, Ilaria Rocco, Gabriella Cirmena, Salvatore Casciaro, Francesca Olcese, Ivana Pierri, Antonia Cagnetta, Fabio Ferrando, Riccardo Ghio, Marco Gobbi, Alberto Ballestrero, Franco Patrone, Alessio Nencioni

Blood (2009) 113 (23): 6035–6037.

https://doi.org/10.1182/blood-2009-03-209213

Published: 2009

Journal Articles

Compared Molecular Monitoring of BCR-ABL Transcripts in Peripheral Blood and Bone Marrow Samples in CML Patients after Allogeneic Hematopoiteic Stem Cell Transplant.

Alida Dominietto, MD, Gabriella Cirmena, Anna Garuti, Anna Maria Raiola, MD, Adalberto Ibatici, MD, Maria Teresa van Lint, MD, Francesco Frassoni, MD, Andrea Bacigalupo, MD

Blood (2006) 108 (11): 5339.

https://doi.org/10.1182/blood.V108.11.5339.5339

Published: 2006

Journal Articles

Treatment of Minimal Residual Disease (MRD) with Donor Lymphocyte Infusions (DLI) in Acute Leukemia Patients Undergoing an Allogeneic Hemopoietic Stem Cell Transplants (HSCT).

Alida Dominietto, MD, Giovanna Piaggio, MD, Sarah Pozzi, MD, Francesca Bertolotti, MD, Nicoletta Colombo, MD, Raffaella Grasso, MD, Anna Garuti, MD, Gabriella Cirmena, MD, Maurizio Miglino, MD, Anna Maria Raiola, MD, Maria Teresa van Lint, MD, Francesco Frassoni, MD, Marina Podesta’, MD, Andrea Bacigalupo, MD

Blood (2005) 106 (11): 2012.

https://doi.org/10.1182/blood.V106.11.2012.2012

Published: 2005

Journal Articles

The Persistence of p190 BCR-ABL Transcripts Is Associated with Lower Probability of Molecular Response to Imatinib in Early and Late Chronic Phase CML Patients.

Anna Garuti, PhD, Adalberto Ibatici, MD, Gabriella Cirmena, PhD, Maurizio Miglino, MD, Riccardo Varaldo, MD, Colombo Nicoletta, PhD, Roberta Grasso, PhD, Sarah Pozzi, PhD, Marina Podesta, PhD, Marco Gobbi, MD, Mario Sessarego, MD, Franco Patrone, MD, Francesco Frassoni, MD

Blood (2005) 106 (11): 3282.

https://doi.org/10.1182/blood.V106.11.3282.3282

Published: 2005

NARROW

Hedgehog Signaling Is Useful as a Novel Molecular Marker for Predicting Relapse and Resistance During Chronic Myeloid Leukemia Treatment.

Catastrophic NAD + Depletion in Activated T Lymphocytes through Nampt Inhibition Reduces Demyelination and Disability in EAE.

Potent Synergistic Activity of the NAD+ Synthesis Inhibitor APO866 and of the Apoptosis Inducer TRAIL in in Vitro and Ex Vivo Cellular Models of Non Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia.

Finding of Kinase Domain Mutations at Diagnosis IN PATIENTS with Chronic PHASE Chronic Myeloid Leukemia (CP-CML) MAY Identify Those at High RISK of Disease Progression.

APO866 activity in hematologic malignancies: a preclinical in vitro study

Compared Molecular Monitoring of BCR-ABL Transcripts in Peripheral Blood and Bone Marrow Samples in CML Patients after Allogeneic Hematopoiteic Stem Cell Transplant.

Treatment of Minimal Residual Disease (MRD) with Donor Lymphocyte Infusions (DLI) in Acute Leukemia Patients Undergoing an Allogeneic Hemopoietic Stem Cell Transplants (HSCT).

The Persistence of p190 BCR-ABL Transcripts Is Associated with Lower Probability of Molecular Response to Imatinib in Early and Late Chronic Phase CML Patients.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only